Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 9, Issue 8, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-08
DOI
10.1038/s41408-019-0225-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
- (2019) Tarinee Rungjirajittranon et al. BMC CANCER
- Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
- (2018) Malin Hultcrantz et al. ANNALS OF INTERNAL MEDICINE
- Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders
- (2018) Abdulkerim Yildiz et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms
- (2018) Joëlle Lapoirie et al. Journal of Maternal-Fetal & Neonatal Medicine
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
- (2018) Ofir Wolach et al. Science Translational Medicine
- Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018
- (2018) Guido Finazzi et al. Blood Cancer Journal
- Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
- (2018) Valerio De Stefano et al. Blood Cancer Journal
- The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
- (2018) Valerio De Stefano et al. Blood Cancer Journal
- Polycythemia vera treatment algorithm 2018
- (2018) Ayalew Tefferi et al. Blood Cancer Journal
- A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges
- (2018) Paola Lanuti et al. Scientific Reports
- High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation
- (2018) Kai Wille et al. ANNALS OF HEMATOLOGY
- Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
- (2018) Alexandre Guy et al. HAEMATOLOGICA
- JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
- (2018) Bärbel Edelmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
- (2018) Anna Guadall et al. THROMBOSIS AND HAEMOSTASIS
- Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy
- (2018) Martin Griesshammer et al. Expert Review of Hematology
- Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera
- (2018) Tiziano Barbui et al. Blood Cancer Journal
- Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases
- (2018) Valerio De Stefano et al. Blood Cancer Journal
- Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms
- (2017) Jean-Christophe Ianotto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management
- (2016) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians
- (2016) A. Kaifie et al. ANNALS OF HEMATOLOGY
- JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms
- (2016) Chi Hua Sarah Lin et al. BLOOD CELLS MOLECULES AND DISEASES
- Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study
- (2016) Samah Alimam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
- (2016) A. Kaifie et al. Journal of Hematology & Oncology
- High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
- (2016) V De Stefano et al. LEUKEMIA
- Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction
- (2016) Federica Boraldi et al. PLoS One
- Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks
- (2016) Netanel A. Horowitz et al. THROMBOSIS AND HAEMOSTASIS
- Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment
- (2016) Silvia Betti et al. THROMBOSIS AND HAEMOSTASIS
- Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
- (2016) V De Stefano et al. Blood Cancer Journal
- A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
- (2016) Valentina Rosso et al. Oncotarget
- Hematologic malignancies during pregnancy: A review
- (2016) Hossam K. Mahmoud et al. Journal of Advanced Research
- Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
- (2015) Juan-Carlos Hernández-Boluda et al. ANNALS OF HEMATOLOGY
- White blood cell counts and thrombosis in polycythemia vera: a subanalysis of the CYTO-PV study
- (2015) T. Barbui et al. BLOOD
- Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism
- (2015) Antonio Gómez-Outes et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
- (2015) T Barbui et al. Blood Cancer Journal
- Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms An European Leukemia Net study
- (2014) Ida Martinelli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
- (2014) Stephan Kreher et al. ANNALS OF HEMATOLOGY
- A primer on genomic and epigenomic alterations in the myeloproliferative neoplasms
- (2014) Raajit Rampal et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia
- (2014) G. Finazzi et al. BLOOD
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
- (2014) S. Leah Etheridge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: A physician survey
- (2014) Martin H. Ellis et al. THROMBOSIS RESEARCH
- Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
- (2013) Maria Luigia Randi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
- (2013) A. Tefferi et al. BLOOD
- Platelet activation and inhibition in polycythemia vera and essential thrombocythemia
- (2013) C. Patrono et al. BLOOD
- Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
- (2013) G. Barosi et al. BLOOD
- Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
- (2013) G. Rotunno et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Myeloproliferative neoplasms and thrombosis
- (2013) T. Barbui et al. BLOOD
- Cytoreduction plus low-dose aspirinversuscytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational study
- (2013) Alberto Alvarez-Larrán et al. BRITISH JOURNAL OF HAEMATOLOGY
- Personalized management of essential thrombocythemia—application of recent evidence to clinical practice
- (2013) A Tefferi et al. LEUKEMIA
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: A role for the JAK2 V617F mutation re-evaluation
- (2013) Donatella Colaizzo et al. THROMBOSIS RESEARCH
- Essential thrombocythemia as a risk factor for stillbirth
- (2013) Takeshi Umazume et al. THROMBOSIS RESEARCH
- Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
- (2012) S. Pascale et al. BLOOD
- Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
- (2012) T. Barbui et al. BLOOD
- Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
- (2012) V. Rosti et al. BLOOD
- Myeloproliferative Neoplasms
- (2012) Julie Kim et al. DM DISEASE-A-MONTH
- Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH
- (2012) T. BAGLIN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report
- (2012) Marc L. Berger et al. VALUE IN HEALTH
- JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients
- (2011) M. Panova-Noeva et al. BLOOD
- Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms
- (2011) L. Teofili et al. BLOOD
- Recommendations for Planning Pilot Studies in Clinical and Translational Research
- (2011) Charity G. Moore et al. CTS-Clinical and Translational Science
- MicroRNA-mediated regulation of the angiogenic switch
- (2011) Sudarshan Anand et al. CURRENT OPINION IN HEMATOLOGY
- Essential thrombocythemia and pregnancy
- (2011) Marie-Cécile Valera et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Myeloproliferative Disorders in Pregnancy
- (2011) Claire N. Harrison et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
- (2010) A. Alvarez-Larran et al. BLOOD
- Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway
- (2010) Y. Dong et al. CARCINOGENESIS
- Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients
- (2010) F. Palandri et al. HAEMATOLOGICA
- Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting
- (2010) C. KEARON et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker
- (2009) G. Piaggio et al. BLOOD
- JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- (2009) F. Dentali et al. BLOOD
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
- (2009) S. Sozer et al. BLOOD
- The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy
- (2009) A. Dragani et al. BLOOD
- Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo
- (2009) Selcuk Sozer et al. BLOOD CELLS MOLECULES AND DISEASES
- Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies
- (2009) F. PASSAMONTI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy
- (2008) Martin Griesshammer et al. BLOOD REVIEWS
- Green tea catechins inhibit angiogenesis through suppression of STAT3 activation
- (2008) Hoyee Leong et al. BREAST CANCER RESEARCH AND TREATMENT
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
- (2008) V. De Stefano et al. HAEMATOLOGICA
- Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
- (2008) Alessandra Carobbio et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started